DISEASE INDICATIONS: Gynaecological Cancer

MANUFACTURER: Clovis Oncology, Inc.

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Rubraca (rucaparib) is a medication used to treat certain types of ovarian cancer, including advanced ovarian cancer that has relapsed or progressed despite previous treatment.